Biotech Commercial Launch - Commercial launch web for biotechs from Phase 3 to New Drug Application to first launch.

Phase 3 to New Drug Application to first commercial launch is a compressed calendar, not a content project. HCP, medical-affairs, and brand sites have to land on the same date, against a content model medical, legal, and commercial can actually publish. We design that architecture before the label is final, so the sites are ready when it is.

• Phase 3 to New Drug Application
• First commercial launch
• Shared content model
• Cross-functional publishing
• One architecture, three sites

Healthcare providers will not wait for a field follow-up. The HCP site has to put the label, the data, and the materials in their hands without a ticket. We have already shipped a five-brand HCP portal that reached 100% HCP self-service and held at the top HCP decile. That is the bar, not a stretch goal.

• HCP portal
• Self-service access
• Multi-brand
• Label and clinical data
• No ticket for the HCP

Medical affairs cannot run on whatever is left over from the brand build. Scientific content, congress materials, and MSL support need their own information architecture, permissions, and review chain. We build that as a first-class site with the same launch date as commercial, not a microsite that trails it.

• Medical affairs
• Scientific content
• Review workflows
• MSL support
• First-class, not leftover

The brand site is the public face of a first launch. It has to be live on day one, with a component system your commercial team can iterate after the agency of record rotates. We build it so your people own publishing, and so HCP and medical-affairs content is not copy-pasted into a separate stack.

• Brand site
• Day-one launch
• Component system
• Team-owned publishing
• Shared with HCP and medical